Clearbridge Investments LLC Increases Stake in Novo Nordisk A/S (NYSE:NVO)

Rufina Vignone
Agosto 2, 2017

Sustainable Growth Advisers LP now owns 4,068,896 shares of the company's stock worth $139,482,000 after buying an additional 598,644 shares in the last quarter.

Want to see what other hedge funds are holding NVO? The Firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The stock declined 4.48% or $5.25 reaching $111.88 on the news. About 15,004 shares traded. Finally, Shamrock Asset Management LLC increased its position in Novo Nordisk A/S by 3.3% in the first quarter.

Other large investors also recently added to or reduced their stakes in the company.

Tracking the RSI levels for Novo Nordisk A/S (NVO), the 3-day RSI stands at 56.37, the 7-day sits at 48.71 and the 14-day (most common) is at 48.46. The 14-day ADX for Novo Nordisk A/S (NVO) is 12.35. About 2.26M shares traded.

Novo Nordisk A/S (NYSE:NVO) opened at 42.16 on Monday. It has underperformed by 40.63% the S&P500.

Investors sentiment increased to 0.98 in Q4 2016. Its up 0.04, from 0.94 in 2016Q3. It is positive, as 84 investors sold NKE shares while 443 reduced holdings. Renaissance Technologies Llc sold 707,600 shares as the company's stock rose 15.20% with the market. Johnson Inv Counsel reported 162,982 shares or 0.25% of all its holdings. 993.29 million shares or 0.55% less from 998.81 million shares in 2016Q3 were reported. Ray Gerald L Assocs holds 0.19% or 12,250 shares. Geode Mgmt Ltd Liability Corp holds 0.01% or 127,738 shares in its portfolio. 1492 Cap Ltd Liability stated it has 2,043 shares. Bessemer Group Inc. raised its stake in Novo Nordisk A/S by 0.7% in the second quarter. More interesting news about Nike Inc (NYSE:NKE) were released by: and their article: "Nike To Begin Selling Products On Amazon" published on July 26, 2017 as well as's news article titled: "Is It Time To Buy Nike's Stock?" with publication date: July 17, 2017. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and four have issued a buy rating to the company. BNP Paribas upgraded the stock to "Outperform" rating in Tuesday, September 13 report. Finally, BidaskClub cut Novo Nordisk A/S from a "buy" rating to a "hold" rating in a research note on Thursday, June 29th. Oppenheimer upgraded the shares of CARB in report on Tuesday, October 11 to "Outperform" rating. The firm earned "Buy" rating on Monday, July 31 by Cowen & Co. The company was maintained on Wednesday, June 29 by Citigroup. The firm has "Buy" rating by BMO Capital Markets given on Friday, July 21.

Among 13 analysts covering Novo Nordisk (ADR) (NYSE:NVO), 4 have Buy rating, 1 Sell and 8 Hold. Therefore 31% are positive. TheStreet raised Novo Nordisk A/S from a "c+" rating to a "b-" rating in a report on Tuesday, May 2nd. Novo Nordisk A/S presently has a consensus rating of "Hold" and an average target price of $53.00. Bank of America downgraded the shares of NVO in report on Friday, October 28 to "Underperform" rating. As per Monday, February 8, the company rating was downgraded by UBS. The company was upgraded on Monday, October 19 by Jyske Bank. The firm has "Market Perform" rating given on Friday, August 28 by Leerink Swann. The correct version of this report can be viewed at JP Morgan downgraded the stock to "Neutral" rating in Friday, September 9 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Altre relazioni OverNewsmagazine

Discuti questo articolo